Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kybella for Submental Fat Reduction
NCT01426373Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Aug 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sodium deoxycholate in submental fullness, sponsored by Kythera Biopharmaceuticals. Primary endpoint: Adverse Events at 18 months. Started Aug 2011; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fullness
Beyond the preview
Go deeper on NCT01426373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426373.